Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the establishment of a new North American team and facilities to advance development of the Company’s platform for discovery of rejuvenation gene targets. Based in Toronto, Canada, the team will be led by Lucas Camillo, Head of Machine Learning, with Professor Bo Wang appointed as Senior Advisor. By expanding into this AI hub, the Company gains access to top machine learning talent, enabling it to further strengthen its IP portfolio and develop new capabilities for its virtual cell platform.
With an estimated 2024 market share of 32.92%, North America is a global hotspot for AI and machine learning scientists. Following the close of the…